Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Human CD30 Ligand/TNFSF8 quantitates human CD30 Ligand/TNFSF8 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD30 Ligand/TNFSF8.
The ligand for CD30 is CD30L (CD153). The binding of CD30 to CD30L mediates pleiotropic effects including cell proliferation, activation, differentiation, and apoptotic cell death. CD30 has a critical role in the pathophysiology of Hodgkin's disease and other CD30+ lymphomas. CD30 acts as a costimulatory molecule in thymic negative selection. In addition to its expression on Hodgkin's and Reed-Sternberg cells, CD30 is also found in some non-Hodgkin's lymphomas (including Burkitt's lymphomas), virus-infected T and B cells, and on normal T and B cells after activation. In T cells, CD30 expression is present on a subset of T cells that produce Th2-type cytokines and on CD4+/CD8+ thymocytes that coexpress CD45RO and the IL4 receptor.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
基因别名 : CD153, CD30L, CD30LG, TNFSF8, TNLG3A
基因ID : (Human) 944
基因符号 : TNFSF8
蛋白别名 : CD153, CD153 antigen, CD30 antigen ligand, CD30 ligand, CD30-L, CD30ligand, tumor necrosis factor (ligand) superfamily, member 8, tumor necrosis factor ligand 3A, Tumor necrosis factor ligand superfamily member 8, tumor necrosis factor superfamily member 8, unnamed protein product
UniProt ID (Human) P32971